Healthcare
Gilde Healthcare buys Europin
The GP will merge it with portfolio company Acti-Med
Warburg Pincus, Mubadala buy Informa's Pharma Intelligence for GBP 1.9bn
GPs pay 20-25x EBITDA for the asset, according to two sources close
Lauxera closes first health tech fund on EUR 260m
Debut fund will invest EUR 20m-40m in European and US health technology companies
EQT, Verdane exit Forsta to Press Ganey
Forsta was formed through the merger of Confirmit and FocusVision in March 2021
Abac exits PronoKal to Nestlé Health Science for EUR 100m
GP first bought 100% of the share capital in 2017
Five Arrows Growth Capital leads EUR 80m fundraise for Padoa
Kamet Ventures will retain a majority stake in the startup
Syz, Saturnus buy SK Pharma
Pharmaceutical wholesaler has been growing at a 28% compound annual growth rate
Polaris V holds final close on EUR 650m hard-cap
Fund has EUR 690m to deploy including the GP commitment, and has made five platform investments
Limerston buys Wickham Micro, appoints new CEO
Deal is a spin-out from Gosport-based Wickham Laboratories
Montagu gears up for Arkopharma exit
Auction process for the food supplement company is expected to take place in H2 2022
Silverfleet reaps 2.6x in Care Fertility sale to Nordic Capital
Nordic Capital buys the IVF clinics chain for GBP 300m, equating to 15.7x EBITDA
Silverfleet's Care Fertility nears sale to Nordic Capital
Bid is expected to draw a line under a competitive auction that was launched in December 2021
Vivalto to close first EUR 700m fund in summer
New GP specialising in healthcare has already deployed 65% of the fund's target
Abris buys dentistry supplier Dentstore
Dentstore is Abris's third acquisition in the dental supplies sector, after Dentotal and Dentechnica
Eleven Ventures announces EUR 60m fund
Eleven Fund III is 10x bigger than its predecessor fund, which launched in 2018 and closed on EUR 6m
Summa holds EUR 2.3bn final close for Fund III
GP will continue its focus on resource efficiency, changing demographics, and tech-enabled companies
Permira merges Kedrion, BPL
Combined biotechnology group will have more than EUR 1.1bn in revenues and 4,000 employees
Buy-and-build a "super opportunity" for PE in healthcare services – panel
Dermatology, ophthalmology and diagnostic imaging all present attractive consolidation opportunities, panellists said
Triton acquires Clinigen at increased GBP 1.3bn valuation
Triley Bidco will acquire Clinigen at a price of 925 pence per share; its previous offer of 833 pence was rejected in December 2021
Ardian acquires Biofarma from White Bridge
GP bought the company from White Bridge Investments
GHO Capital backs biotech RoslinCT
RoslinCT is a spin-out from the University of Edinburgh
KKR closes USD 4bn healthcare fund
Health Care Strategic Growth Fund II is the successor to HCSG I, which closed in November 2017 on USD 1.45bn
EQT sells WS Audiology to new fund
EQT VIII and Santos Holding will buy the company from EQT VI
Gyrus Capital's Essential Pharma refinances, inks two deals
In parallel with the refinancing, Essential Pharma completed two M&A deals in December